180 related articles for article (PubMed ID: 34555725)
1. dockECR: Open consensus docking and ranking protocol for virtual screening of small molecules.
Ochoa R; Palacio-Rodriguez K; Clemente CM; Adler NS
J Mol Graph Model; 2021 Dec; 109():108023. PubMed ID: 34555725
[TBL] [Abstract][Full Text] [Related]
2. Benchmarked molecular docking integrated molecular dynamics stability analysis for prediction of SARS-CoV-2 papain-like protease inhibition by olive secoiridoids.
Thangavel N; Albratty M
J King Saud Univ Sci; 2023 Jan; 35(1):102402. PubMed ID: 36338939
[TBL] [Abstract][Full Text] [Related]
3. Towards Effective Consensus Scoring in Structure-Based Virtual Screening.
Nhat Phuong D; Flower DR; Chattopadhyay S; Chattopadhyay AK
Interdiscip Sci; 2023 Mar; 15(1):131-145. PubMed ID: 36550341
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of consensus scoring methods for AutoDock Vina, smina and idock.
Masters L; Eagon S; Heying M
J Mol Graph Model; 2020 May; 96():107532. PubMed ID: 31991303
[TBL] [Abstract][Full Text] [Related]
5. Combination of pose and rank consensus in docking-based virtual screening: the best of both worlds.
Scardino V; Bollini M; Cavasotto CN
RSC Adv; 2021 Oct; 11(56):35383-35391. PubMed ID: 35424265
[TBL] [Abstract][Full Text] [Related]
6. DockingPie: a consensus docking plugin for PyMOL.
Rosignoli S; Paiardini A
Bioinformatics; 2022 Sep; 38(17):4233-4234. PubMed ID: 35792827
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into the substrate-binding site of main protease for the structure-based COVID-19 drug discovery.
Firouzi R; Ashouri M; Karimi-Jafari MH
Proteins; 2022 May; 90(5):1090-1101. PubMed ID: 35119780
[TBL] [Abstract][Full Text] [Related]
8. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation.
Bepari AK; Reza HM
PeerJ; 2021; 9():e11261. PubMed ID: 33954055
[TBL] [Abstract][Full Text] [Related]
10. Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease.
Manelfi C; Gossen J; Gervasoni S; Talarico C; Albani S; Philipp BJ; Musiani F; Vistoli G; Rossetti G; Beccari AR; Pedretti A
Molecules; 2021 Feb; 26(4):. PubMed ID: 33557115
[TBL] [Abstract][Full Text] [Related]
11. Compromise in Docking Power of Liganded Crystal Structures of M
Zajaček D; Dunárová A; Bucinsky L; Štekláč M
J Chem Inf Model; 2024 Mar; 64(5):1628-1643. PubMed ID: 38408033
[TBL] [Abstract][Full Text] [Related]
12. Calculating an optimal box size for ligand docking and virtual screening against experimental and predicted binding pockets.
Feinstein WP; Brylinski M
J Cheminform; 2015; 7():18. PubMed ID: 26082804
[TBL] [Abstract][Full Text] [Related]
13. De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations.
Arshia AH; Shadravan S; Solhjoo A; Sakhteman A; Sami A
Comput Biol Med; 2021 Dec; 139():104967. PubMed ID: 34739968
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: the prediction accuracy of sampling power and scoring power.
Wang Z; Sun H; Yao X; Li D; Xu L; Li Y; Tian S; Hou T
Phys Chem Chem Phys; 2016 May; 18(18):12964-75. PubMed ID: 27108770
[TBL] [Abstract][Full Text] [Related]
15. Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19.
Talluri S
Comb Chem High Throughput Screen; 2021; 24(5):716-728. PubMed ID: 32798373
[TBL] [Abstract][Full Text] [Related]
16. Comparative Assessment of Docking Programs for Docking and Virtual Screening of Ribosomal Oxazolidinone Antibacterial Agents.
Buckley ME; Ndukwe ARN; Nair PC; Rana S; Fairfull-Smith KE; Gandhi NS
Antibiotics (Basel); 2023 Feb; 12(3):. PubMed ID: 36978331
[TBL] [Abstract][Full Text] [Related]
17. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
Azeem M; Mustafa G; Mahrosh HS
Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
[TBL] [Abstract][Full Text] [Related]
18. RmsdXNA: RMSD prediction of nucleic acid-ligand docking poses using machine-learning method.
Tan LH; Kwoh CK; Mu Y
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38695120
[TBL] [Abstract][Full Text] [Related]
19. Strengths and Weaknesses of Docking Simulations in the SARS-CoV-2 Era: the Main Protease (Mpro) Case Study.
Llanos MA; Gantner ME; Rodriguez S; Alberca LN; Bellera CL; Talevi A; Gavernet L
J Chem Inf Model; 2021 Aug; 61(8):3758-3770. PubMed ID: 34313128
[TBL] [Abstract][Full Text] [Related]
20. A multi-stage virtual screening of FDA-approved drugs reveals potential inhibitors of SARS-CoV-2 main protease.
Mandour YM; Zlotos DP; Alaraby Salem M
J Biomol Struct Dyn; 2022 Mar; 40(5):2327-2338. PubMed ID: 33094680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
